Neurological side-effects of linezolid manifesting as a posterior reversible leuco-encephalopathy syndrome (PRES) is rare. Early identification of this offending drug might reverse this catastrophic event. We report a 45-year-old female, who was diagnosed as a case of disseminated tuberculosis and was treated with antitubercular drugs (ATT), but later developed ATT-induced hepatitis. She was then put on modified ATT (moxifloxacin, terizidone, and linezolid). In the next two days she developed an altered sensorium. Brain imaging was suggestive of PRES. Linezolid was withdrawn, following which she showed an excellent clinical and radiological recovery.

1. Narita, M, Tsuji, BT, Yu, VL. Linezolid-associated peripheral and optic neuropathy, lactic acidosis, and serotonin syndrome. Pharmacotherapy 2007; 27: 1189–1197.
Google Scholar | Crossref | Medline | ISI2. Fletcher, J, Aykroyd, LE, Feucht, EC, et al. Early onset probable linezolid-induced encephalopathy. J Neurol 2010; 257: 433–435.
Google Scholar | Crossref | Medline3. Thai, XC, Bruno-Murtha, LA. Bell's palsy associated with linezolid therapy: case report and review of neuropathic adverse events. Pharmacotherapy 2006; 26: 183–189.
Google Scholar | Crossref4. Shneker, BF, Baylin, PD, Nakhla, ME. Linezolid inducing complex partial status epilepticus in a patient with epilepsy. Neurology 2009; 72: 378–379.
Google Scholar | Crossref | Medline5. Hinchey, J, Chaves, C, Appignani, B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 1996; 334: 494–500.
Google Scholar | Crossref | Medline | ISI6. Gilbert, BW, Gabriel, A, Velazquez, L. A case of antibiotic-induced posterior reversible encephalopathy syndrome. Hosp Pharm 2020; 55: 338–341.
Google Scholar | SAGE Journals | ISI7. Bitar De Zayas-Enriquez, A, Soper, C. Daptomycin-Induced posterior reversible encephalopathy syndrome (PRES). Case Rep Neurol Med 2019; 2019: 8756932.
Google Scholar | Medline8. El-Sheikh, S, Memon, M, Mujtaba, A, et al. An uncommon cause of posterior reversible encephalopathy syndrome related to antibiotic ingestion. Cureus 2018; 10: 3540.
Google Scholar9. Nagel, S, Köhrmann, M, Huttner, HB, et al. Linezolid-induced posterior reversible leukoencephalopathy syndrome. Arch Neurol. 2007; 64: 746–748.
Google Scholar | Crossref | Medline10. Russell, ME, Ivanhoe, CB, Verduzco-Gutierrez, M. Rehabilitation of a 46-year-old woman with subarachnoid hemorrhage complicated by linezolid-induced posterior reversible encephalopathy syndrome (pres): a case report. P M and R - The Journal of Injury, Function and Rehabilitation 4: S378. No. 10, Oct 2012 – USA.
Google Scholar | Crossref11. Rupprecht, TA, Pfister, HW. Clinical experience with linezolid for the treatment of central nervous system infections. Eur J Neurol. 2005; 12: 536–542.
Google Scholar | Crossref | Medline | ISI12. De Vriese, AS, Coster, RV, Smet, J, et al. Linezolid-induced inhibition of mitochondrial protein synthesis. Clin Infect Dis. 2006; 42: 1111–1117.
Google Scholar | Crossref | Medline | ISI13. Almoussa M, Goertzen A, Brauckmann S, et al. Posterior reversible encephalopathy syndrome due to hypomagnesemia: a case report and literature review. Case Rep Med. 2018; 29: 1–6.
Google Scholar | Crossref